|
Odell
v. Legal Bucks, LLC, 665 S.E.2d 767 (North Carolina
Court of Appeals 2008)
Co-counsel in action challenging practice of litigation
funding--whereby lenders advance funds to litigants and
often extract 100% or more annual interest from
litigation proceeds. The Court of Appeals ruled that
practice violates North Carolina's usury laws and
constitutes Unfair and Deceptive Trade Practice.
Murphy v. Federal Deposit Insurance Corporation,
61 F.3d 34 (D.C. Cir. 1995), 208 F.3d 959 (11th Cir.
2000),
cert. dismissed, 531 U.S. 1107 (2001).
Wrote appellate
briefs in action that overturned 50-year-old federal
common law doctrine in United States Court of Appeals
for District of Columbia Circuit. Settled one week
before oral argument in United States Supreme Court.
McLaney v. First Carolina Communications, Inc.,
No. 96-CVS-194 (Superior Court of Watauga County, North
Carolina)
Co-counsel in
class action representing approximately 500 limited
partners in cable television enterprise. Plaintiffs
alleged they were squeezed out and paid less than market
value for their shares. Settled after two weeks of trial
for $5.2 million.
In
re: Fifth Degree Concerts, Inc.,
02-32674 (Bankr. W.D.N.C.)
Forced entity that
had allegedly sold worthless investments into
involuntary bankruptcy. Then, as special counsel to
bankruptcy trustee, helped obtain six-figure recovery
for bankruptcy estate.
Hashemi v. Town of Cary,
2005 WL 1150210, 2005 WL 2277304 (North Carolina Court
of Appeals)
Appellate counsel
for aggrieved owner of commercial property in Cary,
North Carolina, whose tract was allegedly rendered
undevelopable by town's riparian buffer ordinance.
Owner's action challenging validity of Town's ordinance
had been dismissed in Wake County Superior Court.
Court of Appeals reinstated action on ground that that
"the Cary Ordinance appears to require a greater
riparian buffer than that required by the State."
Prescription Drug Litigation [Parties' Names Withheld]
(Guilford County, North Carolina)
Co-counsel in
class action representing over 1,400 persons who were
allegedly required to purchase certain prescription
drugs at inflated prices. Settled; class members
received reimbursement of approximately 100% of alleged
overpayments.
Securities Fraud Litigation [Parties' Names Withheld]
|
John F. Bloss
- Partner
